Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Applied Therapeutics Inc (APLT)

Applied Therapeutics Inc (APLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 531,342
  • Shares Outstanding, K 114,267
  • Annual Sales, $ 9,990 K
  • Annual Income, $ -119,760 K
  • 60-Month Beta 2.03
  • Price/Sales 53.90
  • Price/Cash Flow N/A
  • Price/Book 7.72
Trade APLT with:

Options Overview Details

View History
  • Implied Volatility 101.64% ( -153.73%)
  • Historical Volatility 166.15%
  • IV Percentile 18%
  • IV Rank 18.73%
  • IV High 303.64% on 10/16/23
  • IV Low 55.08% on 06/24/24
  • Put/Call Vol Ratio 0.48
  • Today's Volume 23,507
  • Volume Avg (30-Day) 1,504
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 25,786
  • Open Int (30-Day) 22,167

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.13
  • Number of Estimates 2
  • High Estimate -0.11
  • Low Estimate -0.14
  • Prior Year -0.47
  • Growth Rate Est. (year over year) +72.34%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.55 +72.53%
on 09/16/24
8.41 -6.69%
on 09/18/24
+2.00 (+34.19%)
since 08/16/24
3-Month
4.20 +86.90%
on 06/26/24
8.41 -6.69%
on 09/18/24
+3.35 (+74.44%)
since 06/18/24
52-Week
1.79 +338.55%
on 11/27/23
9.39 -16.40%
on 02/28/24
+5.87 (+296.46%)
since 09/18/23

Most Recent Stories

More News
Why Applied Therapeutics Stock Is Skyrocketing Today

Investors are cheering good news from the FDA.

APLT : 7.85 (+68.82%)
Stocks Set to Open Higher as Investors Await U.S. Jobs Data and Fed Speak

June S&P 500 E-Mini futures (ESM24) are up +0.10%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.14% this morning as investors digested the latest U.S. inflation figures and looked ahead to remarks...

ESM24 : 5,471.89s (-0.09%)
NQM24 : 19,747.29s (-0.08%)
EL : 88.00 (-0.11%)
WBA : 9.01 (-0.55%)
RH : 334.68 (+1.19%)
MLKN : 27.69 (+0.95%)
CURV : 4.29 (-2.05%)
APLT : 7.85 (+68.82%)
T : 21.73 (-0.23%)
CCJ : 40.11 (-0.47%)
DVN : 40.37 (-0.22%)
BILL : 51.66 (+2.05%)
S&P Futures Tick Lower as Key U.S. Jobs Report Looms

March S&P 500 E-Mini futures (ESH24) are trending down -0.23% this morning as investors looked ahead to the crucial monthly U.S. nonfarm payrolls report for further clues on the timing of possible interest-rate...

ESH24 : 5,101.67s (-1.01%)
WBA : 9.01 (-0.55%)
MBLY : 11.61 (-1.94%)
AAPL : 220.69 (+1.80%)
ALL : 191.01 (+0.39%)
EDV.LN : 1,802.000 (-1.74%)
LIGHT.NA : 21.080 (-1.40%)
PTON : 4.43 (-3.70%)
APLT : 7.85 (+68.82%)
IBM : 214.94 (+0.38%)
FUSN : 21.55 (+0.14%)
PLTR : 36.38 (-0.19%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Applied Therapeutics, Inc. (NASDAQ: APLT)

/PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Applied Therapeutics, Inc. (NASDAQ: APLT) concerning possible breaches of...

APLT : 7.85 (+68.82%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Applied Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

APLT : 7.85 (+68.82%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Applied Therapeutics, Inc. (NASDAQ: APLT)

/PRNewswire/ -- Levi & Korsinsky announces that it has commenced an investigation of Applied Therapeutics, Inc. (NASDAQ: APLT) concerning possible breaches of...

APLT : 7.85 (+68.82%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Applied Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

APLT : 7.85 (+68.82%)
Applied Therapeutics, Inc. Announces Pricing of $30 Million Public Offering of Common Stock and Warrants

NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company...

APLT : 7.85 (+68.82%)
Applied Therapeutics, Inc. Announces Public Offering of Common Stock and Warrants

NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company...

APLT : 7.85 (+68.82%)
Applied Therapeutics Receives Orphan Medicinal Product Designation from the EMA for AT-007 for Treatment of Galactosemia

NEW YORK, June 03, 2022 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline...

APLT : 7.85 (+68.82%)

Business Summary

Applied Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing drug candidates for unmet medical need. The company's product candidate consists of AT-001, for the treatment of Diabetic Cardiomyopathy; AT-007, for the treatment of Galactosemia and AT-003, for the treatment...

See More

Key Turning Points

3rd Resistance Point 10.64
2nd Resistance Point 9.53
1st Resistance Point 8.69
Last Price 7.85
1st Support Level 6.74
2nd Support Level 5.62
3rd Support Level 4.78

See More

52-Week High 9.39
Last Price 7.85
Fibonacci 61.8% 6.49
Fibonacci 50% 5.59
Fibonacci 38.2% 4.69
52-Week Low 1.79

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar